SAN DIEGO & AUCKLAND, New Zealand--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD), and Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today announced an agreement to settle all outstanding patent ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

The New Zealand sharemarket fell nearly 0.5% and was dragged down by its leading stock, Fisher & Paykel Healthcare, on sector ...

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep ...

Fisher & Paykel Healthcare Corporation Limited ( (FSPKF)) has released its Q2 earnings. Here is a breakdown of the information Fisher & Paykel Healthcare Corporation Limited presented to its investors ...

Fisher & Paykel Healthcare: Limited Recall Doesn’t Impact Our Long-Term View We maintain our NZD 23.50 fair value estimate for narrow-moat Fisher & Paykel Healthcare, or AUD 22.00 at current exchange ...

In a report released today, Shane Storey from Wilsons upgraded Fisher & Paykel Healthcare Corporation Limited (FSPKF – Research Report) to a Buy, with a price target of A$35.00. The company’s shares ...

In a report released on November 28, Adrian Allbon from Jarden maintained a Sell rating on Fisher & Paykel Healthcare Corporation Limited (FSPKF – Research Report). The company’s shares closed last ...

Fisher & Paykel Healthcare Corp. Ltd. Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, ...

Fisher & Paykel Healthcare Corp. Ltd. Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, ...